SUMMARY Of 76 children with histiocytosis X 18 had orbital involvement, and four developed additional neuro-ophthalmic complications. No instance of intraocular involvement was detected. Among those patients with ophthalmic involvement the main problems were bilateral or unilateral proptosis, ptosis, papilloedema, optic atrophy, and seventh nerve palsy. Only one patient developed a severe visual defect. Management of the ophthalmological complications depends not only on the extent of the orbital disease but also on the degree of systemic involvement. Overall management by a paediatric oncologist is mandatory.
Histiocytosis X is an uncommon multisystem disorder of unknown aetiology, which is characterised by accumulation of histiocytes in various tissues and which runs a variable clinical course. It is predominantly a disease of childhood but is occasionally seen in adults. ' It has an affinity for the orbit. Ophthalmologists may be asked to see children with disseminated disease who develop proptosis during the course of their illness, but isolated orbital involvement is sometimes the presenting feature.
Histiocytosis X was a term first proposed by Lichtenstein in 19522 to cover three related disorders, eosinophilic granuloma, Hand-Schuller-Christian disease, and Letterer-Siwe disease, which he believed were different clinical expressions of a single nosological entity. 'Eosinophilic granuloma' was first coined by Lichtenstein and Jaffe' to describe a single histiocytic lesion in bone, but it was later used to describe a condition where the histiocytic lesions, which may be multiple, were confined to bone. The original description of Hand-Schuller-Christian disease was of the triad of exophthalmos, bony defects of the skull, and diabetes insipidus. Strictly speaking this exact combination is rare,'45 but the eponym is sometimes used to describe the chronic disseminated form of histiocytosis X involving both bone and soft tissues. Letterer-Siwe disease usually occurs in infancy with widespread soft tissue and visceral involvement with or without bony lesions, and it has a subacute, and sometimes fatal, course.
Newton and Hamoudi6 have correlated histo-
Corrcspondcncc to Mr D S I Taylor, FRCS. 7 logical appearance with clinical prognosis and proposed a histopathological classification of histiocytosis X, but this has not gained widespread acceptance. 7 As it is not possible to distinguish these three groups on histopathological appearance of involved tissues, and as there is considerable clinical overlap between the three conditions,' it is now generally agreed that the generic term histiocytosis X should be used in preference to the eponymous subclassification.
We present here our experience with histiocytosis X and discuss the clinical features and management of the ophthalmological complications of this condition.
Material and methods
The case records of all children with histiocytosis X seen at the Hospital for Sick Children over a 26-year period from 1957 were reviewed for evidence of ocular or orbital involvement with histiocytosis X. Owing partly to changes in referral patterns half the patients had presented in the last six years.
Results
The records of 76 patients were examined. The age range was from birth to 12 years, and 30% were under the age of one year at presentation (Fig. 1) .
The majority of patients (39) orbital involvement in this latter group (Table 1) . Three patients had diabetes insipidus at presentation, and a further nine patients developed it at a later stage. Classical Hand-Schuller-Christian disease, with bilateral proptosis, diabetes insipidus, and bony defects of the skull, was seen in only two patients.
Eighteen patients developed orbital involvement with histiocytosis X, half of these from the time of presentation. In 16 the diagnosis of histiocytosis X was confirmed by histopathology. Each of the two patients who did not have biopsies showed the typical clinical and radiological features of chronic disseminated histiocytosis X. Eleven patients developed unilateral proptosis, five developed bilateral proptosis, and two presented with unilateral ptosis in association with a localised orbital lytic lesion. Of particular interest are three patients who presented with isolated orbital involvement with histiocytosis X. Two of these patients showed spontaneous resolution of their disease after biopsy, and in the third case (case 2) the disease ran an unusually locally aggressive Fig. 2A) . Eye examination was otherwise normal. X-rays of the left orbit showed an area of bone destruction at the superolateral aspect of the left orbit (Figs. 2B, C), and orbital CT scan showed a small extraconal mass at the lateral side of the left orbit. General examination, liver scan, bone scan, skeletal survey, bone marrow examination, and urinary osmolality were all normal. Biopsy of the lesion showed the typical histological appearance of histiocytosis X. No treatment was given, and the ptosis and orbital mass resolved over the next five months (Fig. 2D ). X-ray examination at this time showed healing of the orbital lesion. He has remained well with no recurrence of histiocytosis X.
Case 2. This 8-year-old boy presented in March 1980 with a history of a left periorbital swelling present for two months. He had been born in England of Jamaican parents, and apart from frequent upper respiratory tract infections in childhood had been generally well. On examination the vision was 6/6 RE and 6/9 LE. A rubbery mass was palpable around the upper and lower orbital margins and extending over the lateral wall and down over the zygoma. There was 6 mm of left axial proptosis (Fig.  3A) , but eye movements, pupil reactions, and fundus examination were normal. X-rays of the orbit showed a lytic lesion of the lateral wall, and CT scan showed a left orbital mass (Fig. 3B) . A biopsy of the orbital mass showed the typical appearance of histiocytosis X. General examination, chest x-ray, skeletal survey, bone marrow, and urinary osmolalities were all normal.
Because there was no shrinkage after excision biopsy and because of the cosmetic appearance, the left orbit was treated in July 1980 with radiotherapy (1000 cgray). Initially there was a favourable response, but by the end of 1981 the mass had extended to involve the temporal fossa, and a large tumour mass was evident on the surface of the skin (Fig. 3C) . The degree of proptosis and visual acuity was unchanged. In February 1982 the main part of the lesion was excised, and the underlying abnormal tissue curetted from the bone leaving a large defect in the lateral orbital wall and over the maxilla. Histology of the excised tissue again showed histiocytosis X. Depo-Medrone 80 mg (methyleprednisolone acetate), and Solu-medrone 100 mg (methylprednisolone sodium succinate) were injected into the residual tumour on four occasions over the next six months, and the tumour became smaller. When the patient was last seen in December 1982 the vision was 6/6 RE and 6/9 LE. There was 6 mm of left axial proptosis (Fig. 3D ), but eye examination was otherwise normal. He has developed no further manifestations of histiocytosis X.
Case 3. This 21/2-year-old Pakistani girl presented in July 1978 with fever and bilateral proptosis. There was bilateral axial proptosis, but eye examirnation was otherwise normal. There was a palpable mass on the vertex of the skull and over the left zygoma, an eczematous rash on the scalp, and a palpable liver and spleen. Skull x-ray showed several lytic lesions, and biopsy of one of the skull lesions showed histiocytosis X (Fig. 4) . Chest x-ray and bone marrow examination were normal. Treatment was started with prednisolone and vinblastine, and when reviewed three months later she appeared to be I-Io. iI) responding to treatment, and the proptosis was less marked.
Chemotherapy was stopped in March 1979, but this was soon followed by worsening of her bilateral proptosis and the appearance of new lesions of the skull and zygoma. Her pupil reactions and fundus examination were normal. CT scan showed bilateral soft tissue masses in both orbits with bilateral invasion of the middle cranial fossa. Chemotherapy was restarted, and both orbits, pituitary areas, and middle cranial fossa were treated with radiotherapy (1500 cgray). She returned to Pakistan, where treatment was continued with prednisolone, vinblastine, and, later, cyclophosphamide.
In May 1981 she returned to London for review. She had been drowsy and vomiting for one month. On examination the proptosis was more marked. There was a mass in the left upper lid, a left relative afferent pupil defect, and bilateral disc oedema. CT scan (Fig. 7) showed increased size of the orbital masses, dilated third and fourth ventricles, and oedema of both temporal lobes. She initially improved on dexamethasone, but when she was reexamined six months later there was again a left afferent pupil defect, but now there was bilateral optic atrophy thought to be secondary to raised intracranial pressure. CT scan showed bilateral orbital masses and low attention in both temporal lobes and posterior fossa. A ventriculoperitoneal shunt was inserted and a brain biopsy taken, which confirmed cerebral involvement with histiocytosis X. Postoperatively the vision deteriorated. There was no pupillary response to light, and there was bilateral optic atrophy. Electrodiagnostic tests showed a normal ERG but absent visual evoked response from each eye. The patient returned to Pakistan and we have no further follow-up. In patients with histiocytosis X orbital involvement is, however, common, and with some exceptions''" is usually seen in the chronic form of the disease" especially 'Eosinophilic granuloma'.7 The overall incidence of orbital involvement in larger series of patients with histiocytosis X is about 20% , but only half of these patients developed proptosis.' 2 In our series 23% of patients had clinical signs of orbital involvement, and most had proptosis. There may be radiological evidence of orbital involvement without any accompanying cljnical signs, but proptosis is almost invariably associated with a lytic lesion of the orbital wall.' In our study there were no cases of orbital involvement in patients whose disease was confined to the soft tissue ( Secondary open-angle glaucoma," bilateral perforating corneal ulcers,"' and posterior scleritis"2 have also been reported.
In contrast, orbital involvement is rare in the acute disseminated form of histiocytosis X5 as confirmed in this study. It is usually seen in patients with the chronic disseminated form. Optic neuropathy and cranial nerve palsies are rare 17-4 as the orbital mass is usually extraconal, and destruction of the orbital walls may result in orbital decompression. Beller and Kornbleuth,'7 however, reported a 14-year-old boy who developed optic neuropathy and third, fourth, and sixth cranial nerve palsies. The optic nerve and chiasm may become involved by intracranial histiocytosis X, which has a predilection for the pituitary gland.' Papilloedema and secondary optic atrophy may result from raised intracranial pressure secondary to intracranial involvement with histiocytosis Xv Although orbital and pituitary involvement with histiocytosis X was commonly seen in our series, only four patients developed neuro-ophthalmic complications.
The diagnosis of histiocytosis X is ultimately confirmed by histopathological examination of biopsy specimens of involved tissues. In children with orbital involvement as part of systemic disease it is usually easier to take a biopsy specimen from another site such as the scalp, or a peripheral bony lesion. In isolated orbital involvement the diagnosis should be suspected when a child presents with periorbital swelling, ptosis, or proptosis, and there is evidence of a lytic lesion on x-ray, with or without a narrow zone of sclerosis (Fig. 2B) . The radiological appearances are, however, variable'7 and may resemble Ewing's sarcoma, oesteomyelitis, metastatic tumourespecially neuroblastoma or lymphoblastic leukaemia -or even fibrous dysplasia. The diagnosis may, therefore, be in doubt until histopathology is available. In children with isolated orbital involvement it is usually possible to take a biopsy specimen from the involved orbital bone without having to enter the orbit. The bone will be found to be infiltrated by soft yellow-brown material which is easily curetted. .Orbital histiocytosis X must be differentiated from other histocytic disorders which may involve the orbit, such as sinus histiocytosisx v and juvenile xanthogranuloma (JXG). These conditions, however, usually remain confined to the orbital soft tissues and do not involve bone, although JXG may rarely result in orbital bony destruction.4"4' If there are no other systemic features, it may be difficult to distinguish between orbital histiocytosis X and JXG clinically, but light and electron microscopy of a biopsy specimen are diagnostic.
Children whose disease is confined to a single system such as bone or skin have a good prognosis, though there may be a later recurrence in about one-third of cases.' In patients with a single bony lesion biopsy and curettage may be followed by spontaneous resolution, as occurred in two of our patients. However, if there is marked proptosis, or a cosmetically unacceptable lesion of the orbital wall, or evidence of optic nerve involvement, a short course of systemic steroids or radiotherapy may be used in an attempt to induce remission. A radiation dose of 500-60() cgray is usually sufficient and a total dose of not more than 1000 cgray is recommended.4"
There is no evidence that lesions which do not respond to 1000 cgray will respond to a higher dose, and because of the fear of radiation induced malignancy later in life this dose should be exceeded only in exceptional circumstances. An alternative approach to disfiguring lesions of the orbital wall is to remove the main mass of the lesion surgically, with curettage of the underlying bone. Intralesional steroids as used in Case 2 may also be tried.4TM The relative infrequency of optic nerve compression and the good response to radiotherapy or chemotherapy means that surgical exploration of the orbit is rarely necessary. In patients with disseminated histiocytosis X, orbital disease, causing proptosis, will generally respond to systemic chemotherapy, though local radiotherapy may be used in addition if there is progressive proptosis or optic nerve involvement. In view of the tendency to spontaneous regression, in both single system disease (as illustrated in case 1) and in multisystem44 disease, we recommend a conservative therapeutic approach, including an initial period of observation, without specific therapy.
The most frequently used systemic agents are prednisone, vincristine, or vinblastine, and the epipodophyllotoxin VP16. The response rate to multidrug regimens is no greater than to single or double agent therapy, and the complication rate is higher." Therefore, we commence chemotherapy, if it is needed, with prednisone alone, adding vincristine where the response to steroids is inadequate and using VP16 in resistant disease.
Recent investigations have shown a subtle immunological defect in patients with histiocytosis X. Osband et al. 45 found a relative suppressor cell deficiency in the peripheral blood mononuclear cells of patients with multiple organ involvement. This finding has been confirmed in a separate group of children (including one of the patients reported here) with histiocytosis X limited to the skeletal system. 46 Though immunohistochemical studies confirm that the histiocytosis X disease process is characterised by abnormal accumulation of histiocytes, including Langerhans cells,47 it is not yet clear whether suppressor cell deficiency is the cause of the disordered histiocytic proliferation or an unrelated 'secondary' effect. However, the presence of the same immunological abnormality in patients with both single system and multisystem disease adds weight to the clinical' and histopathological7 evidence supporting Lichtenstein's 'unifying' concept of the histiocytosis X disorders. 2 After demonstrating that the suppressor cell deficiency could be corrected in vitro by 'thymosin' (a crude extract of calf thymus), the Boston group administered this material intramuscularly to a group of children with newly diagnosed histiocytosis X. 45 The overall 'response rate' was 60%, a figure comparable with that achieved with chemotherapy. In London we have studied the effects of synthetic analogues (TP1 and TP5) believed to represent the active moiety of 'thymosin'. Though we confirmed that the reduced suppressor: helper lymphocyte ratio was corrected by TP1 or TP5 in the majority of patients, there was no clinical response to these preparations in five patients. 46 Because of the tendency to spontaneous remission in histiocytosis X44 it is essential that future studies of novel forms of therapy, such as thymic hormones, include controlled, randomised trials.
The prognosis in histiocytosis X depends upon New cases of histiocytosis X presenting to the ophthalmologist are best managed in collaboration with a paediatric oncologist. Advice from other specialists such as ENT and orthopaedic surgeons may be needed for specific problems. Even if there is no clinical evidence of systemic involvement, chest xray, skeletal survey, bone marrow examination, lung and liver function tests, and early morning urine specific gravity are needed to assess the extent of the disease and will determine the appropriate treatment.
